{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":19,"n_cols":5,"rows_kept":19,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[12,2,12,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910788295403321"]
[null,null,"Titolo",null,"TRP channels as therapeutic targets : from basic science to clinical use / / edited by Arpad Szallasi ; contributors, M. Allen McAlexander [and fifty-nine others]"]
[null,null,"Pubbl/distr/stampa",null,"Amsterdam, [Netherlands] : , : Academic Press, , 2015"]
[{"$nulls":4},"©2015"]
[null,null,"Descrizione fisica",null,"1 online resource (530 p.)"]
[null,null,"Disciplina",null,"572.696"]
[null,null,"Soggetti",null,"TRP channels"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references at the end of each chapters and index."]
[null,null,"Nota di contenuto",null,"Front Cover; TRP Channels as Therapeutic Targets: From Basic Science to Clinical Use; Copyright; Contents; Contributors; Preface; Chapter 1: An Introduction to Transient Receptor Potential Ion Channels and Their Roles in Disease; Discovery and General Properties of TRP Channels; TRP Channels in Normal Physiology; TRP Channels and Sensory Physiology; TRP Channels and Cardiovascular Function; TRP Channels and Gastrointestinal Function; TRP Channels and Urological Function; TRP Channels and the Brain; TRP Channels and Immune Function; TRP Channels and Development; TRP Channels and Disease"]
[{"$nulls":4},"Therapeutic Strategies Based on TRP Channel ModulationAcknowledgment; References; Chapter 2: Transient Receptor Potential Dysfunctions in Hereditary Diseases: TRP Channelopathies and Beyond; Introduction; TRPC Channelopathies; TRPV Channelopathies; TRPM Channelopathies; TRPA Channelopathies; TRPML Channelopathies; TRPP Channelopathies; Conclusions; Acknowledgments; References; Chapter 3: The Role of TRPV1 in Acquired Diseases: Therapeutic Potential of TRPV1 Modulators; Introduction; TRPV1 and Pain; TRPV1 and Gastrointestinal System-Related Disease; TRPV1 and Urinary System-Related Diseases"]
[{"$nulls":4},"TRPV1 and Central Nervous System-Related DiseasesTRPV1 and Respiratory System-Related Diseases; TRPV1 and Cancer; TRPV1 and Cardiovascular System-Related Diseases; TRPV1 and Metabolic Diseases; TRPV1 and Other Disease Conditions; Conclusions; Acknowledgment; References; Chapter 4: TRP Gene Polymorphism and "]
[{"$nulls":4},"Disease Risk; TRP Gene Polymorphism; TRPA1 ; The TRPC Subfamily; The TRPM Subfamily; The TRPML Subfamily; The TRPV Subfamily; Disease Risk, Clinical Diagnosis, and Personalized Medicine; References; Chapter 5: Use of Topical Capsaicin for Pain Relief; Introduction; Pharmacodynamics"]
[{"$nulls":4},"PharmacokineticsEfficacy and Therapeutic Uses; Postherpetic Neuralgia; HIV -Associated Distal Sensory Polyneuropathy; Other Neuropathic Pain States; Safety and Tolerability; Delivery of Treatment with Capsaicin 8% Patch-Practical Aspects; Application Procedure for the Capsaicin 8% Patch; Postprocedural Instructions for Patients; References; Chapter 6: TRPV1 Agonist Cytotoxicity for Chronic Pain Relief: From Mechanistic Understanding to Clinical Application; Introduction; Mechanisms of TRPV1 Agonist Therapeutic Action; Four Main Determinants of TRPV1 Agonist Actions"]
[{"$nulls":4},"Selectivity of RTX at the Cellular LevelRTX Produces a Prolonged Channel Open Time; TRPV1 Is Selectively Expressed in Subpopulations of DRG Neurons; RTX Is Administered Locally; Companion Dog and Human Studies; Companion (Pet) Dog Models of Chronic Pain; TRPV1 Agonists in the Companion Dog Model of Bone Cancer; TRPV1 Agonists in the Companion Dog Model of Osteoarthritis; Human Studies; References; Chapter 7: Intravesical Capsaicin and Resiniferatoxin for Bladder Disorders; Capsaicin and Resiniferatoxin Targets and Effects in the Urinary Bladder"]
[{"$nulls":4},"The Rationale for Using Vanilloids to Overcome Lower Urinary Tract Symptoms"]